Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Chan

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Technology Assessment in Health Care|September 18, 2012
Order sets in health care: a systematic review of their effectsAlvita J Chan, Julie Chan, Joseph A Cafazzo, et al.
Journal of Vascular Surgery|March 12, 2022
Hemoglobin A1c monitoring practices before lower extremity bypass in patients with diabetes vary broadly and do not predict outcomesEmily Y Fan, Allison S Crawford, Tammy Nguyen, et al.
Molecular Cancer Therapeutics|November 18, 2003
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasionXueyan Wang, Phuong Le, Congxin Liang, et al.
Nucleic Acids Research|October 18, 2017
Aurora Kinase B, a novel regulator of TERF1 binding and telomeric integrityFoong Lyn Chan, Benjamin Vinod, Karel Novy, et al.
Molecules (Basel, Switzerland)|July 9, 2022
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2Joy Y Feng, Venice Du Pont, Darius Babusis, et al.
Nature Communications|November 6, 2021
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferretsRobert M Cox, Josef D Wolf, Carolin M Lieber, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2024
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stabilityAndrew Mulato, Eric Lansdon, Ron Aoyama, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary FibrosisDoris T Tang, Zhimin Du, Kin S Yang, et al.
Journal of Medicinal Chemistry|April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSVRichard L Mackman, Hon C Hui, Michel Perron, et al.
Journal of Medicinal Chemistry|October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological MalignanciesMatthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Technology Assessment in Health Care|September 18, 2012
Order sets in health care: a systematic review of their effectsAlvita J Chan, Julie Chan, Joseph A Cafazzo, et al.
Journal of Vascular Surgery|March 12, 2022
Hemoglobin A1c monitoring practices before lower extremity bypass in patients with diabetes vary broadly and do not predict outcomesEmily Y Fan, Allison S Crawford, Tammy Nguyen, et al.
Molecular Cancer Therapeutics|November 18, 2003
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasionXueyan Wang, Phuong Le, Congxin Liang, et al.
Nucleic Acids Research|October 18, 2017
Aurora Kinase B, a novel regulator of TERF1 binding and telomeric integrityFoong Lyn Chan, Benjamin Vinod, Karel Novy, et al.
Molecules (Basel, Switzerland)|July 9, 2022
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2Joy Y Feng, Venice Du Pont, Darius Babusis, et al.
Nature Communications|November 6, 2021
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferretsRobert M Cox, Josef D Wolf, Carolin M Lieber, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2024
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stabilityAndrew Mulato, Eric Lansdon, Ron Aoyama, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary FibrosisDoris T Tang, Zhimin Du, Kin S Yang, et al.
Journal of Medicinal Chemistry|April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSVRichard L Mackman, Hon C Hui, Michel Perron, et al.
Journal of Medicinal Chemistry|October 28, 2015
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological MalignanciesMatthew T Burger, Gisele Nishiguchi, Wooseok Han, et al.
Pageof 4